Contineum Therapeutics, Inc. (CTNM) — Cash & Equivalents
| Fiscal Year | Cash & Equivalents | Change YoY |
|---|---|---|
| 2025 | $75.60M | +244.5% |
| 2024 | $21.94M | +41.3% |
| 2023 | $15.53M | — |
| Fiscal Year | Cash & Equivalents | Change YoY |
|---|---|---|
| 2025 | $75.60M | +244.5% |
| 2024 | $21.94M | +41.3% |
| 2023 | $15.53M | — |